CUV 3.03% $15.62 clinuvel pharmaceuticals limited

“Objective is to pursue where there is an unmet need. “Yes...

  1. 71 Posts.
    lightbulb Created with Sketch. 29

    “Objective is to pursue where there is an unmet need. “


    Yes that’s a great “objective” but after waiting a record breaking length of time by stonewalling regulators only to be lockdown approved and handed a very small opportunity …… EPP!…… why would you not have done everything humanly possible to exploit that slight crack in their armour?

    …….. Hello!!……

    <10% on scenesse after 5-10 years might be enough sales revenue to guarantee one’s outrageous remuneration, but the remaining 90% left without any treatment is not only a wasted opportunity, it’s a horrible look that even an amateur would know that numbers like that would only create a great deal of concern and uncertainty.

    Its whats been allowing the shorter to manipulate the SP for years because everything else is “another couple years off”.

    They wouldn’t be here if >50% were on scenesse and still growing (even if slowly) it’s better than “plateauing” ………. Massive fail and squandered opportunity when we’ve only been handed(because of implant safety) 1……….. Bring on AGM 2024!!

    Last edited by Melon felon!: 28/04/24
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.62
Change
0.460(3.03%)
Mkt cap ! $782.6M
Open High Low Value Volume
$15.08 $15.67 $15.08 $1.510M 97.41K

Buyers (Bids)

No. Vol. Price($)
1 211 $15.55
 

Sellers (Offers)

Price($) Vol. No.
$15.62 49 1
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
$15.59
  Change
0.460 ( 3.27 %)
Open High Low Volume
$15.30 $15.66 $15.30 8124
Last updated 15.59pm 14/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.